◀ Back to TP53

TP53 — UBE2K

Protein-Protein interactions - manually collected from original source literature:

Studies that report less than 10 interactions are marked with *

• IRef Biogrid Interaction: UBE2K — TP53 (direct interaction, enzymatic study) Saville et al., J Biol Chem 2004*
• IRef Biogrid Interaction: UBE2K — TP53 (physical association, affinity chromatography technology) Bae et al., Biochim Biophys Acta 2013*
• IRef Biogrid Interaction: UBE2K — TP53 (direct interaction, protein complementation assay) Bae et al., Biochim Biophys Acta 2013*
• IRef Hprd Interaction: TP53 — UBE2K (in vivo) Kikuchi et al., Arterioscler Thromb Vasc Biol 2000*
• IRef Ophid Interaction: UBE2K — TP53 (aggregation, interologs mapping) Brown et al., Bioinformatics 2005

Text-mined interactions from Literome

Leng et al., Cell 2003 : Pirh2, a p53 induced ubiquitin-protein ligase , promotes p53 degradation
Wesierska-Gadek et al., J Cell Biochem 2007 (Breast Neoplasms) : Roscovitine activated HIP2 kinase induces phosphorylation of wt p53 at Ser-46 in human MCF-7 breast cancer cells
Wu et al., J Mol Neurosci 2012 (Brain Injuries) : Pirh2, a p53 induced ubiquitin-protein ligase , has been reported to promote ubiquitin dependent degradation of p27 ( kip1 ), which plays an essential role in mammalian cell cycle regulation and neurogenesis in the developing central nervous system ( CNS )